Detalhe da pesquisa
1.
Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling.
Rep Pract Oncol Radiother
; 27(6): 933-942, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632308
2.
Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results.
J Thorac Oncol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788924
3.
Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial.
Clin Cancer Res
; 28(9): 1800-1808, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275991
4.
Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study.
J Thorac Oncol
; 16(2): 259-268, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334571
5.
Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study.
J Thorac Oncol
; 2020 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756882
6.
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.
Lung Cancer
; 138: 79-87, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654838
7.
Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.
J Thorac Oncol
; 14(1): 63-71, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391573
8.
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group]. / Drobnokomórkowy rak pluca - zalecenia diagnostyczno-terapeutyczne Polskiej Grupy Raka Pluca.
Pneumonol Alergol Pol
; 75(1): 88-94, 2007.
Artigo
em Polonês
| MEDLINE | ID: mdl-17541917
9.
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Oncotarget
; 8(10): 17270-17278, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27924059
10.
(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
Eur J Cancer
; 42(12): 1698-701, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16765588
11.
Prisoners' attitudes towards cigarette smoking and smoking cessation: a questionnaire study in Poland.
BMC Public Health
; 6: 181, 2006 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16827930
12.
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).
Clin Cancer Res
; 22(10): 2386-95, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26747242
13.
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.
J Thorac Oncol
; 7(2): 340-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237262
14.
Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.
J Thorac Oncol
; 7(6): 982-92, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22551903
15.
The role of pemetrexed combined with targeted agents for non-small cell lung cancer.
Curr Drug Targets
; 11(1): 2-11, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19839932